Satoshi Ogasawara

Biography

Publications

• Structural basis of anticancer drug recognition and amino acid transport by LAT1.

  Lee Y, Jin C, Ohgaki R, Xu M, Ogasawara S, Warshamanage R, Yamashita K, Murshudov G, Nureki O, Murata T, Kanai Y. Nat Commun 2025 Feb 14

  PMID: 39952931

• Na+-V-ATPase inhibitor curbs VRE growth and unveils Na+ pathway structure.

  Suzuki K, Goto Y, Otomo A, Shimizu K, Abe S, Moriyama K, Yasuda S, Hashimoto Y, Kurushima J, Mikuriya S, Imai FL, Adachi N, Kawasaki M, Sato Y, Ogasawara S, Iwata S, Senda T, Ikeguchi M, Tomita H, Iino R, Moriya T, Murata T. Nat Struct Mol Biol 2025

  PMID: 39572733

• Improved higher resolution cryo-EM structures reveal the binding modes of hERG channel inhibitors.

  Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda S, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T. Structure 2024 Nov 07

  PMID: 39321803

• Enhancement of transcription efficiency by TAR-Tat system increases the functional expression of human olfactory receptors.

  Ojiro I, Katsuyama H, Kaneko R, Ogasawara S, Murata T, Terada Y, Ito K. PLoS One 2025

  PMID: 38917199

• Non-invasive hERG channel screening based on electrical impedance tomography and extracellular voltage activation (EIT-EVA).

  Ihsan MF, Kawashima D, Li S, Ogasawara S, Murata T, Takei M. Lab Chip 2024 06 11

  PMID: 38828904